NEFL and myeloid sarcoma: Increased abundance of inflammatory cytokines (e.g. tumour necrosis factor-α) and the axonal marker (neurofilament light chain) in the CSF have been proposed as early biomarkers to diagnose MS and/or optic neuritis in patients (Olesen et al. 2019).